FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1554600230> ?p ?o ?g. }

• W1554600230 endingPage "572" @default.
• W1554600230 startingPage "567" @default.
• W1554600230 abstract "Abstract Twenty-four patients with acute promyelocytic leukemia (APL) were treated with all-trans retinoic acid (45 to 100 mg/m2/day). Of these, eight cases had been either nonresponsive or resistant to previous chemotherapy; the other 16 cases were previously untreated. All patients attained complete remission without developing bone marrow hypoplasia. Bone marrow suspension cultures were studied in 15 of the 24 patients. Fourteen of these patients had morphological maturation in response to the retinoic acid (1 mumol/L). Chloroacetate esterase and alpha-naphthyl acetate esterase staining as well as electronmicroscopic examination confirmed that retinoic acid-induced cells differentiated to granulocytes with increased functional maturation (as measured by nitroblue tetrazolium reduction, NBT). The single nonresponder to retinoic acid in vitro was resistant to treatment with retinoic acid but attained complete remission after addition of low-dose cytosine arabinoside (ara-C). During the course of therapy, none of the patients showed any abnormalities in the coagulation parameters we measured, suggesting an absence of any subclinical disseminated intravascular coagulation. The only side effects consisted of mild dryness of the lips and skin, with occasional headaches and digestive symptoms. Eight patients have relapsed after 2 to 5 months of complete remission. The others remain in complete remission at 1+ to 11+ months and are still being followed up. We conclude that all-trans retinoic acid is an effective inducer for attaining complete remission in APL." @default.
• W1554600230 created "2016-06-24" @default.
• W1554600230 creator A5017452303 @default.
• W1554600230 creator A5021018087 @default.
• W1554600230 creator A5026873909 @default.
• W1554600230 creator A5027470460 @default.
• W1554600230 creator A5050020375 @default.
• W1554600230 creator A5077146317 @default.
• W1554600230 creator A5082509799 @default.
• W1554600230 creator A5088330681 @default.
• W1554600230 date "1988-08-01" @default.
• W1554600230 modified "2023-10-14" @default.
• W1554600230 title "Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia" @default.
• W1554600230 cites W103351882 @default.
• W1554600230 cites W1503457234 @default.
• W1554600230 cites W1976528127 @default.
• W1554600230 cites W2013554303 @default.
• W1554600230 cites W2023968523 @default.
• W1554600230 cites W2025228940 @default.
• W1554600230 cites W2037949275 @default.
• W1554600230 cites W2046699743 @default.
• W1554600230 cites W204832425 @default.
• W1554600230 cites W2053306416 @default.
• W1554600230 cites W2076426515 @default.
• W1554600230 cites W2085686347 @default.
• W1554600230 cites W2094387567 @default.
• W1554600230 cites W2105559291 @default.
• W1554600230 cites W2141083396 @default.
• W1554600230 cites W2218895233 @default.
• W1554600230 cites W2273144074 @default.
• W1554600230 cites W2329211716 @default.
• W1554600230 cites W2415995382 @default.
• W1554600230 cites W2424946676 @default.
• W1554600230 cites W2471504264 @default.
• W1554600230 cites W2917541409 @default.
• W1554600230 cites W345013177 @default.
• W1554600230 cites W49201907 @default.
• W1554600230 cites W92934419 @default.
• W1554600230 doi "https://doi.org/10.1182/blood.v72.2.567.567" @default.
• W1554600230 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2696695" @default.
• W1554600230 hasPublicationYear "1988" @default.
• W1554600230 type Work @default.
• W1554600230 sameAs 1554600230 @default.
• W1554600230 citedByCount "2208" @default.
• W1554600230 countsByYear W15546002302012 @default.
• W1554600230 countsByYear W15546002302013 @default.
• W1554600230 countsByYear W15546002302014 @default.
• W1554600230 countsByYear W15546002302015 @default.
• W1554600230 countsByYear W15546002302016 @default.
• W1554600230 countsByYear W15546002302017 @default.
• W1554600230 countsByYear W15546002302018 @default.
• W1554600230 countsByYear W15546002302019 @default.
• W1554600230 countsByYear W15546002302020 @default.
• W1554600230 countsByYear W15546002302021 @default.
• W1554600230 countsByYear W15546002302022 @default.
• W1554600230 countsByYear W15546002302023 @default.
• W1554600230 crossrefType "journal-article" @default.
• W1554600230 hasAuthorship W1554600230A5017452303 @default.
• W1554600230 hasAuthorship W1554600230A5021018087 @default.
• W1554600230 hasAuthorship W1554600230A5026873909 @default.
• W1554600230 hasAuthorship W1554600230A5027470460 @default.
• W1554600230 hasAuthorship W1554600230A5050020375 @default.
• W1554600230 hasAuthorship W1554600230A5077146317 @default.
• W1554600230 hasAuthorship W1554600230A5082509799 @default.
• W1554600230 hasAuthorship W1554600230A5088330681 @default.
• W1554600230 hasBestOaLocation W15546002301 @default.
• W1554600230 hasConcept C104317684 @default.
• W1554600230 hasConcept C126322002 @default.
• W1554600230 hasConcept C134018914 @default.
• W1554600230 hasConcept C203014093 @default.
• W1554600230 hasConcept C2776601000 @default.
• W1554600230 hasConcept C2778461978 @default.
• W1554600230 hasConcept C2779963572 @default.
• W1554600230 hasConcept C2780007613 @default.
• W1554600230 hasConcept C2781121885 @default.
• W1554600230 hasConcept C55493867 @default.
• W1554600230 hasConcept C71924100 @default.
• W1554600230 hasConcept C86803240 @default.
• W1554600230 hasConcept C90924648 @default.
• W1554600230 hasConceptScore W1554600230C104317684 @default.
• W1554600230 hasConceptScore W1554600230C126322002 @default.
• W1554600230 hasConceptScore W1554600230C134018914 @default.
• W1554600230 hasConceptScore W1554600230C203014093 @default.
• W1554600230 hasConceptScore W1554600230C2776601000 @default.
• W1554600230 hasConceptScore W1554600230C2778461978 @default.
• W1554600230 hasConceptScore W1554600230C2779963572 @default.
• W1554600230 hasConceptScore W1554600230C2780007613 @default.
• W1554600230 hasConceptScore W1554600230C2781121885 @default.
• W1554600230 hasConceptScore W1554600230C55493867 @default.
• W1554600230 hasConceptScore W1554600230C71924100 @default.
• W1554600230 hasConceptScore W1554600230C86803240 @default.
• W1554600230 hasConceptScore W1554600230C90924648 @default.
• W1554600230 hasIssue "2" @default.
• W1554600230 hasLocation W15546002301 @default.
• W1554600230 hasOpenAccess W1554600230 @default.
• W1554600230 hasPrimaryLocation W15546002301 @default.
• W1554600230 hasRelatedWork W2017638479 @default.
• W1554600230 hasRelatedWork W2023968523 @default.

• next